Eric Topol on Nostr: The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity ...
Published at
2025-01-04 18:34:04Event JSON
{
"id": "8f3d0fe5a6389e2535c8fba3f60e98f6a09a068b42851dc20028bdcf76b55389",
"pubkey": "5077f486a3f2f72d07e0efd5cb00aa243734739327371edd92d5c63a7b7dfe53",
"created_at": 1736015644,
"kind": 1,
"tags": [
[
"imeta",
"url https://media.mstdn.social/media_attachments/files/113/771/521/053/153/126/original/ce832d7abbc7e194.png",
"m image/png",
"dim 1058x1042",
"blurhash UaMk009Jo$ITD+D+WERj~pRiaet7oet7Rjt7"
],
[
"proxy",
"https://mstdn.social/users/erictopol/statuses/113771521277492439",
"activitypub"
]
],
"content": "The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity and testing them for prevention of Alzheimer's disease—Lotte Bjerre Knudsen— tells her story in a remarkable conversation. Full transcript, or video, all free, no ads.\nhttps://erictopol.substack.com/p/lotte-bjerre-knudsen-the-scientist\n\nhttps://media.mstdn.social/media_attachments/files/113/771/521/053/153/126/original/ce832d7abbc7e194.png",
"sig": "d36fc4b2944c3432a399f24c99de1bd359fc2e79f002a04e7baad3ca6cccaa8bf918556ada707cafd7f38a1f02f4e471305868f3cfd9c0cb680562e246564bd3"
}
